Cargando…
Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
Individual growth patterns and cribriform architecture are increasingly considered in risk stratification and clinical decision-making in men with prostate cancer. Our objective was to establish the prognostic value of individual Gleason 5 patterns in a radical prostatectomy (RP) cohort. We reviewed...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514328/ https://www.ncbi.nlm.nih.gov/pubmed/34175896 http://dx.doi.org/10.1038/s41379-021-00860-4 |
_version_ | 1784583358088478720 |
---|---|
author | Hansum, Tim Hollemans, Eva Verhoef, Esther I. Bangma, Chris H. Rietbergen, John Osanto, Susanne Pelger, Rob C. M. van Wezel, Tom van der Poel, Henk Bekers, Elise Helleman, Jozien Remmers, Sebastiaan van Leenders, Geert J. L. H. |
author_facet | Hansum, Tim Hollemans, Eva Verhoef, Esther I. Bangma, Chris H. Rietbergen, John Osanto, Susanne Pelger, Rob C. M. van Wezel, Tom van der Poel, Henk Bekers, Elise Helleman, Jozien Remmers, Sebastiaan van Leenders, Geert J. L. H. |
author_sort | Hansum, Tim |
collection | PubMed |
description | Individual growth patterns and cribriform architecture are increasingly considered in risk stratification and clinical decision-making in men with prostate cancer. Our objective was to establish the prognostic value of individual Gleason 5 patterns in a radical prostatectomy (RP) cohort. We reviewed 1064 RPs and recorded Grade Group (GG), pT-stage, surgical margin status, Gleason 4 and 5 growth patterns as well as intraductal carcinoma. The clinical endpoints were biochemical recurrence and post-operative distant metastasis. Gleason pattern 5 was present in 339 (31.9%) RPs, of which 47 (4.4%) presented as primary, 166 (15.6%) as secondary, and 126 (11.8%) as tertiary pattern. Single cells/cords were present in 321 (94.7%) tumors with Gleason pattern 5, solid fields in 90 (26.5%), and comedonecrosis in invasive carcinoma in 32 (9.4%) tumors. Solid fields demonstrated either a small nested morphology (n = 50, 14.7%) or medium to large solid fields (n = 61, 18.0%). Cribriform architecture was present in 568 (53.4%) RPs. Medium to large solid fields and comedonecrosis coincided with cribriform architecture in all specimens, and were not observed in cribriform-negative cases. In multivariable analysis adjusted for Prostate-Specific Antigen, pT-stage, GG, surgical margin status and lymph node metastases, cribriform architecture (Hazard Ratio (HR) 9.9; 95% Confidence Interval (CI) 3.9–25.5, P < 0.001) and comedonecrosis (HR 2.1, 95% CI 1.2–3.7, P = 0.01) were independent predictors for metastasis-free survival, while single cells/cords (HR 1.2; 95% CI 0.7–1.8, P = 0.55) and medium to large solid fields (HR 1.6, 95% CI 0.9–2.7, P = 0.09) were not. In conclusion, comedonecrosis in invasive carcinoma is an independent prognostic Gleason 5 pattern for metastasis-free survival after RP. These data support the current recommendations to routinely include cribriform pattern in pathology reports and indicate that comedonecrosis should also be commented on. |
format | Online Article Text |
id | pubmed-8514328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85143282021-10-29 Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients Hansum, Tim Hollemans, Eva Verhoef, Esther I. Bangma, Chris H. Rietbergen, John Osanto, Susanne Pelger, Rob C. M. van Wezel, Tom van der Poel, Henk Bekers, Elise Helleman, Jozien Remmers, Sebastiaan van Leenders, Geert J. L. H. Mod Pathol Article Individual growth patterns and cribriform architecture are increasingly considered in risk stratification and clinical decision-making in men with prostate cancer. Our objective was to establish the prognostic value of individual Gleason 5 patterns in a radical prostatectomy (RP) cohort. We reviewed 1064 RPs and recorded Grade Group (GG), pT-stage, surgical margin status, Gleason 4 and 5 growth patterns as well as intraductal carcinoma. The clinical endpoints were biochemical recurrence and post-operative distant metastasis. Gleason pattern 5 was present in 339 (31.9%) RPs, of which 47 (4.4%) presented as primary, 166 (15.6%) as secondary, and 126 (11.8%) as tertiary pattern. Single cells/cords were present in 321 (94.7%) tumors with Gleason pattern 5, solid fields in 90 (26.5%), and comedonecrosis in invasive carcinoma in 32 (9.4%) tumors. Solid fields demonstrated either a small nested morphology (n = 50, 14.7%) or medium to large solid fields (n = 61, 18.0%). Cribriform architecture was present in 568 (53.4%) RPs. Medium to large solid fields and comedonecrosis coincided with cribriform architecture in all specimens, and were not observed in cribriform-negative cases. In multivariable analysis adjusted for Prostate-Specific Antigen, pT-stage, GG, surgical margin status and lymph node metastases, cribriform architecture (Hazard Ratio (HR) 9.9; 95% Confidence Interval (CI) 3.9–25.5, P < 0.001) and comedonecrosis (HR 2.1, 95% CI 1.2–3.7, P = 0.01) were independent predictors for metastasis-free survival, while single cells/cords (HR 1.2; 95% CI 0.7–1.8, P = 0.55) and medium to large solid fields (HR 1.6, 95% CI 0.9–2.7, P = 0.09) were not. In conclusion, comedonecrosis in invasive carcinoma is an independent prognostic Gleason 5 pattern for metastasis-free survival after RP. These data support the current recommendations to routinely include cribriform pattern in pathology reports and indicate that comedonecrosis should also be commented on. Nature Publishing Group US 2021-06-26 2021 /pmc/articles/PMC8514328/ /pubmed/34175896 http://dx.doi.org/10.1038/s41379-021-00860-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hansum, Tim Hollemans, Eva Verhoef, Esther I. Bangma, Chris H. Rietbergen, John Osanto, Susanne Pelger, Rob C. M. van Wezel, Tom van der Poel, Henk Bekers, Elise Helleman, Jozien Remmers, Sebastiaan van Leenders, Geert J. L. H. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
title | Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
title_full | Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
title_fullStr | Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
title_full_unstemmed | Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
title_short | Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
title_sort | comedonecrosis gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514328/ https://www.ncbi.nlm.nih.gov/pubmed/34175896 http://dx.doi.org/10.1038/s41379-021-00860-4 |
work_keys_str_mv | AT hansumtim comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT hollemanseva comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT verhoefestheri comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT bangmachrish comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT rietbergenjohn comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT osantosusanne comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT pelgerrobcm comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT vanwezeltom comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT vanderpoelhenk comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT bekerselise comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT hellemanjozien comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT remmerssebastiaan comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients AT vanleendersgeertjlh comedonecrosisgleasonpattern5isassociatedwithworseclinicaloutcomeinoperatedprostatecancerpatients |